Cargando…
Unexpected Positive Effects of Rituximab and Corticosteroids on COVID-19 in a Patient Suffering from Granulomatosis with Polyangiitis
The COVID-19 pandemic has raised concerns among physicians and patients with autoimmune disorders about how this viral infection affects the patients receiving immunosuppressive drugs. There are speculations about a higher incidence and severity of COVID-19 in patients receiving a variety of immunos...
Autores principales: | Salesi, Mansour, Shojaie, Behrokh, Naderi, Zohre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531733/ https://www.ncbi.nlm.nih.gov/pubmed/34760807 http://dx.doi.org/10.4103/abr.abr_266_20 |
Ejemplares similares
-
Fatal Cytomegalovirus Disease after Combination Therapy with Corticosteroids and Rituximab for Granulomatosis with Polyangiitis
por: Hilal, Talal
Publicado: (2015) -
Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis
por: Endo, Yushiro, et al.
Publicado: (2018) -
A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study
por: Chaleshtori, Maryam Tavakoli, et al.
Publicado: (2022) -
Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies
por: Nakazawa, Maho, et al.
Publicado: (2018) -
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab
por: Geetha, Duvuru, et al.
Publicado: (2014)